Brew I - Search Results

1

Isofagomine Inhibits Multiple TcdB Variants and Protects Mice from Clostridioides difficile-Induced Mortality.

Paparella AS, Brew I, Hong HA, Ferriera W, Cutting S, Lamiable-Oulaidi F, Popadynec M, Tyler PC, Schramm VL. Paparella AS, et al. Among authors: brew i. ACS Infect Dis. 2024 Mar 8;10(3):928-937. doi: 10.1021/acsinfecdis.3c00507. Epub 2024 Feb 9. ACS Infect Dis. 2024. PMID: 38334357

2

Development and optimisation of a reception testing protocol designed to eliminate HCV in the UK prison population.

Mongale E, Allen S, Brew I, Ludlow-Rhodes A, Royal N, Waldron J, Alexander H, Christensen L, Dorrington K, Milner A, Missen L, Jones A, Troke PJF. Mongale E, et al. Among authors: brew i. JHEP Rep. 2023 Oct 16;6(1):100937. doi: 10.1016/j.jhepr.2023.100937. eCollection 2024 Jan. JHEP Rep. 2023. PMID: 38169900 Free PMC article.

3

Chronic hepatitis C elimination prison initiative: HCV-intensive test and treat, a whole prisoner population HCV test-and-treat program in England.

Halford R, Christensen L, Cox S, Sheehan J, Brew I, Gillyon-Powell M, Threadgold G, O'Moore É, Troke PJF, Jones A. Halford R, et al. Among authors: brew i. Health Sci Rep. 2023 Dec 19;6(12):e1724. doi: 10.1002/hsr2.1724. eCollection 2023 Dec. Health Sci Rep. 2023. PMID: 38125280 Free PMC article.

4

Combined inhibition of MTAP and MAT2a mimics synthetic lethality in tumor models via PRMT5 inhibition.

Bedard GT, Gilaj N, Peregrina K, Brew I, Tosti E, Shaffer K, Tyler PC, Edelmann W, Augenlicht LH, Schramm VL. Bedard GT, et al. Among authors: brew i. J Biol Chem. 2024 Jan;300(1):105492. doi: 10.1016/j.jbc.2023.105492. Epub 2023 Nov 23. J Biol Chem. 2024. PMID: 38000655 Free PMC article.

5

Isofagomine inhibits multiple TcdB variants and protects mice from Clostridioides difficile induced mortality.

Paparella AS, Brew I, Hong HA, Ferriera W, Cutting S, Lamiable-Oulaidi F, Popadynec M, Tyler PC, Schramm VL. Paparella AS, et al. Among authors: brew i. bioRxiv [Preprint]. 2023 Sep 19:2023.09.19.558375. doi: 10.1101/2023.09.19.558375. bioRxiv. 2023. Update in: ACS Infect Dis. 2024 Mar 8;10(3):928-937. doi: 10.1021/acsinfecdis.3c00507. PMID: 37781587 Free PMC article. Updated. Preprint.

6

Patient pathway: the ideal approach.

Corless L, Brew I. Corless L, et al. Among authors: brew i. Br J Nurs. 2018 Feb 7;27(Sup3):S14-S19. doi: 10.12968/bjon.2018.27.Sup3.S14. Br J Nurs. 2018. PMID: 29411991

7

Novel psychoactive substances.

Brew I. Brew I. Br J Gen Pract. 2016 Mar;66(644):125. doi: 10.3399/bjgp16X684253. Br J Gen Pract. 2016. PMID: 26917640 Free PMC article. No abstract available.

8

Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis.

Martin NK, Vickerman P, Brew IF, Williamson J, Miners A, Irving WL, Saksena S, Hutchinson SJ, Mandal S, O'Moore E, Hickman M. Martin NK, et al. Among authors: brew if. Hepatology. 2016 Jun;63(6):1796-808. doi: 10.1002/hep.28497. Epub 2016 Mar 22. Hepatology. 2016. PMID: 26864802 Free PMC article.

9

Can antiviral treatment for hepatitis C be safely and effectively delivered in primary care?: a narrative systematic review of the evidence base.

Brew IF, Butt C, Wright N. Brew IF, et al. Br J Gen Pract. 2013 Dec;63(617):e842-51. doi: 10.3399/bjgp13X675421. Br J Gen Pract. 2013. PMID: 24351500 Free PMC article. Review.

10

Post-splenectomy sepsis--the role of occupational health.

Brew I, Adisesh A. Brew I, et al. Occup Med (Lond). 1996 Jun;46(3):231-2. doi: 10.1093/occmed/46.3.231. Occup Med (Lond). 1996. PMID: 8695777

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters